These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7555986)

  • 1. Efficacy and tolerability of vigabatrin in children with refractory partial seizures: a single-blind dose-increasing study.
    Dalla Bernardina B; Fontana E; Vigevano F; Fusco L; Torelli D; Galeone D; Buti D; Cianchetti C; Gnanasakthy A; Iudice A
    Epilepsia; 1995 Jul; 36(7):687-91. PubMed ID: 7555986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentre clinical evaluation of vigabatrin (Sabril) in mild to moderate partial epilepsies. French Neurologists Sabril Study Group.
    Arzimanoglou AA; Dumas C; Ghirardi L
    Seizure; 1997 Jun; 6(3):225-31. PubMed ID: 9203252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant vigabatrin in refractory epilepsy: a ceiling to effective dosage in individual patients?
    McKee PJ; Blacklaw J; Friel E; Thompson GG; Gillham RA; Brodie MJ
    Epilepsia; 1993; 34(5):937-43. PubMed ID: 8404750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vigabatrin withdrawal randomized study in children.
    Chiron C; Dulac O; Gram L
    Epilepsy Res; 1996 Nov; 25(3):209-15. PubMed ID: 8956918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind substitution of vigabatrin and valproate in carbamazepine-resistant partial epilepsy. 012 Study group.
    Brodie MJ; Mumford JP
    Epilepsy Res; 1999 Apr; 34(2-3):199-205. PubMed ID: 10210035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-vinyl GABA (vigabatrin) and mood disturbances.
    Aldenkamp AP; Vermeulen J; Mulder OG; Overweg J; Van Parys JA; Beun AM; Van 't Slot B
    Epilepsia; 1994; 35(5):999-1004. PubMed ID: 7925172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-Response Study of Vigabatrin as add-on therapy in patients with uncontrolled complex partial seizures.
    Dean C; Mosier M; Penry K
    Epilepsia; 1999 Jan; 40(1):74-82. PubMed ID: 9924905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response study of vigabatrin in children with refractory epilepsy.
    Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA
    J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vigabatrin in refractory childhood epilepsy. The Brazilian Multicenter Study.
    Gherpelli JL; Guerreiro MM; da Costa JC; Rotta NT; Manreza ML; Reed UC; Diament A; Silva EA; Guerreiro CA; Nunes ML; Palmini A; Vega-Gutiérrez L; Vizioli J; Pedroso F; Chisté MA
    Epilepsy Res; 1997 Dec; 29(1):1-6. PubMed ID: 9416454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding antiepileptic drug options: clinical efficacy of new therapeutic agents.
    Ben-Menachem E
    Epilepsia; 1996; 37 Suppl 2():S4-S7. PubMed ID: 8641244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].
    Vogt H; Krämer G
    Schweiz Med Wochenschr; 1995 Jan; 125(4):125-32. PubMed ID: 7878401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures.
    Hosford DA; Wang Y
    Epilepsia; 1997 Apr; 38(4):408-14. PubMed ID: 9118845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome: an open study.
    Feucht M; Brantner-Inthaler S
    Epilepsia; 1994; 35(5):993-8. PubMed ID: 7925171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of vigabatrin on partial seizures and cognitive function.
    Grünewald RA; Thompson PJ; Corcoran R; Corden Z; Jackson GD; Duncan JS
    J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1057-63. PubMed ID: 8089668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term open multicentre, add-on trial of vigabatrin in adult resistant partial epilepsy. The Canadian Vigabatrin Study Group.
    Guberman A; Bruni J
    Seizure; 2000 Mar; 9(2):112-8. PubMed ID: 10845734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stiripentol: efficacy and tolerability in children with epilepsy.
    Perez J; Chiron C; Musial C; Rey E; Blehaut H; d'Athis P; Vincent J; Dulac O
    Epilepsia; 1999 Nov; 40(11):1618-26. PubMed ID: 10565591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vigabatrin as add-on therapy in children and adolescents with refractory epilepsy: an open trial.
    Coppola G; Terraciano AM; Pascotto A
    Brain Dev; 1997 Nov; 19(7):459-63. PubMed ID: 9408591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigabatrin as first add-on treatment in carbamazepine-resistant epilepsy patients.
    Murri L; Iudice A
    Acta Neurol Scand Suppl; 1995; 162():40-2. PubMed ID: 7495189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-blind, placebo-controlled multicenter trial of vigabatrin in the treatment of epilepsy. The Italian Study Group on Vigabatrin.
    Ital J Neurol Sci; 1992 Dec; 13(9):741-7. PubMed ID: 1483856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group.
    Chadwick D
    Lancet; 1999 Jul; 354(9172):13-9. PubMed ID: 10406359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.